A detailed history of Consolidated Portfolio Review Corp transactions in Mckesson Corp stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 503 shares of MCK stock, worth $256,650. This represents 0.07% of its overall portfolio holdings.

Number of Shares
503
Holding current value
$256,650
% of portfolio
0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$518.81 - $607.81 $260,961 - $305,728
503 New
503 $294 Million
Q3 2023

Nov 13, 2023

BUY
$402.4 - $446.42 $194,359 - $215,620
483 New
483 $210 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $73.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Consolidated Portfolio Review Corp Portfolio

Follow Consolidated Portfolio Review Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Portfolio Review Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Portfolio Review Corp with notifications on news.